CXSL1900144 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(10) | New Drug Application | 2019-12-31 | 重庆宸安生物制药有限公司 | ChongQing Chenan Biopharmaceutical Co Ltd | In Review | 2019-12-30 | view |
JXSL1300028 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Import Drug Application | 2013-04-17 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2015-08-07 | view |
JYSB1800140 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2018-07-30 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2018-10-09 | view |
JYSB1700181 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2017-10-16 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-11-10 | view |
JXSS1500010 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Import Drug Application | 2015-09-24 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-09-27 | view |
JYSB1700180 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2017-10-16 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-11-10 | view |
JXSS1500011 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Import Drug Application | 2015-09-24 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-09-27 | view |
JYSB1800142 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2018-07-30 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2018-10-09 | view |
CYSB2000168 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2020-07-04 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2021-08-06 | view |
JXSL1300027 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Import Drug Application | 2013-04-26 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2015-08-07 | view |
CXSL1900062 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(10) | New Drug Application | 2019-07-04 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | In Review | 2019-07-03 | view |
CXSL1600073 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(7) | New Drug Application | 2016-10-08 | 海正药业(杭州)有限公司 | Hisun Pharmaceutical (Hangzhou) Co Ltd | Certificate Issued | 2017-12-21 | view |
CXSL1900074 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(15) | New Drug Application | 2019-07-09 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | In Review | 2019-07-08 | view |
CXSL1700063 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(7) | New Drug Application | 2017-08-17 | 吉林津升制药有限公司 | Ji Lin Jin Sheng Pharmaceutical Co Ltd | Certificate Issued | 2018-04-10 | view |
JYSB1700223 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2017-12-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2018-01-10 | view |
JYSB1900259 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2019-09-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-04-21 | view |
JYSB1900258 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2019-09-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-04-21 | view |
JYSB1700222 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2017-12-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2018-01-10 | view |
CXSL2100024 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2021-01-20 | 东莞市东阳光生物药研发有限公司 | Dongguan HEC Biopharmaceutical R&D Co Ltd | In Review | 2021-01-19 | view |
JYSB2101166 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-11-10 | | Novo Nordisk A/S | | | view |